Statistics
Publications
19
Citations
1.4K
H-Index
18
Active since
1997
Thomas Melby is an author at Eli Lilly (United States) specializing in medicine, hiv, and immunology.
Publications per year
1997–2020
19
19
Thomas Melby, Charles N. Ciampaglio, Gina Briscoe et al. · The Journal of Cell Biology · 1998 · 372 citations · Full text
Mike Mink, Sarah Mosier, S. Janumpalli et al. · Journal of Virology · 2005 · 129 citations · Full text
Antiviral Potency, Susceptibility Decreases, Gp41 Binding +15
Short‐Term Safety and Antiretroviral Activity of T‐1249, a Second‐Generation Fusion Inhibitor of HIV
Joseph J. Eron, Roy M. Gulick, John Bartlett et al. · The Journal of Infectious Diseases · 2004 · 126 citations · Full text
Second‐generation Fusion Inhibitor, 39-Aa Synthetic Peptide, Hiv-1-infected Adults +14
Bente Langdahl, Stuart L. Silverman, Saeko Fujiwara et al. · Bone · 2018 · 101 citations · Full text
1–5 of 19